|
2022
|
Invention
|
Sphingosine kinase inhibitors. The invention relates to substituted adamantane compounds, pharmac... |
|
2020
|
Invention
|
Combination of a sk2 inhibitor and an inhibitor of a checkpoint pathway, uses and pharmaceutical ... |
|
|
Invention
|
Methods of inducing an anti-cancer immune response. ex vivoex vivo, with a toxic concentration of... |
|
2017
|
Invention
|
Diaminothiazole compounds, compositions and methods of use. The disclosure relates to diaminothia... |
|
2010
|
Invention
|
Treatment of ischemia-reperfusion injury.
Ischemia-reperfusion injury remains a primary cause of... |
|
|
Invention
|
Treatment of ischemia-reperfusion injury. Ischemia-reperfusion injury remains a primary cause of ... |
|
|
Invention
|
Sphingosine kinase inhibitor prodrugs. The invention relates to prodrugs of hydroxyl-substituted ... |
|
|
Invention
|
Sphingosine kinase inhibitor prodrugs. The invention relates to compounds of the formula (I... |
|
2009
|
Invention
|
Sphingosine kinase inhibitors and methods of their use.
The invention relates to compounds, phar... |
|
2006
|
Invention
|
Sphingosine kinase inhibitors and methods of their use. The invention relates to compounds, pharm... |
|
|
Invention
|
Sphingosine kinase inhibitors. The invention relates to substituted adamantane compounds of... |
|
|
Invention
|
Sphingosine kinase inhibitors. The invention relates to substituted adamantane compounds of formu... |
|
|
Invention
|
Methods for the treatment and prevention of inflammatory diseases. The invention includes process... |
